BlackRock Inc. Acquires New Position in Maximus, Inc. $MMS

Key Points

• BlackRock acquired 7.44 million Maximus shares worth approximately $400.2 million, giving it a 14.17% stake. Institutional investors collectively own 97.21% of the company.
• Maximus reported quarterly EPS of $2.22, slightly above estimates, but revenue of $1.28 billion fell short of expectations and declined 5.1% year over year. The company issued fiscal 2026 EPS guidance of $7.90–$8.20.
• Maximus declared a quarterly dividend of $0.33 per share, equivalent to an annualized $1.32 payout and a 2.3% yield. Analyst sentiment remains cautious, with the stock carrying a consensus “Reduce” rating.

BlackRock Inc. bought a new position in Maximus, Inc. (NYSE:MMS - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 7,443,930 shares of the health services provider's stock, valued at approximately $400,186,000. BlackRock Inc. owned approximately 14.17% of Maximus at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Farther Finance Advisors LLC raised its stake in shares of Maximus by 69.0% during the fourth quarter. Farther Finance Advisors LLC now owns 284 shares of the health services provider's stock worth $25,000 after acquiring an additional 116 shares in the last quarter. Advisory Services Network LLC purchased a new stake in shares of Maximus in the 3rd quarter valued at $32,000. Canada Pension Plan Investment Board purchased a new stake in shares of Maximus in the 2nd quarter valued at $35,000. Northwestern Mutual Wealth Management Co. grew its holdings in shares of Maximus by 225.2% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 439 shares of the health services provider's stock valued at $38,000 after purchasing an additional 304 shares during the last quarter. Finally, Global Retirement Partners LLC bought a new position in shares of Maximus during the 2nd quarter valued at $40,000. 97.21% of the stock is currently owned by institutional investors.

Maximus Stock Performance

Shares of MMS stock opened at $58.54 on Wednesday. The company has a market capitalization of $3.07 billion, a P/E ratio of 8.65 and a beta of 0.59. Maximus, Inc. has a fifty-two week low of $52.73 and a fifty-two week high of $100.00. The company has a debt-to-equity ratio of 0.90, a quick ratio of 2.42 and a current ratio of 2.42. The stock has a 50 day moving average price of $57.51 and a two-hundred day moving average price of $63.91.

Maximus (NYSE:MMS - Get Free Report) last issued its earnings results on Thursday, August 6th. The health services provider reported $2.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.21 by $0.01. Maximus had a net margin of 7.07% and a return on equity of 24.91%. The firm had revenue of $1.28 billion for the quarter, compared to analysts' expectations of $1.33 billion. During the same quarter last year, the business earned $2.16 earnings per share. The business's revenue was down 5.1% on a year-over-year basis. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. Analysts expect that Maximus, Inc. will post 8.01 earnings per share for the current year.

Maximus Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, August 31st. Shareholders of record on Friday, August 14th will be issued a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date of this dividend is Friday, August 14th. Maximus's dividend payout ratio (DPR) is 19.50%.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the stock. Zacks Research cut shares of Maximus from a "hold" rating to a "strong sell" rating in a research report on Tuesday, August 11th. Weiss Ratings restated a "hold (c-)" rating on shares of Maximus in a research report on Monday, August 17th. Finally, Wall Street Zen cut Maximus from a "buy" rating to a "hold" rating in a research note on Saturday, August 8th. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Maximus presently has a consensus rating of "Reduce".

Maximus Profile

Maximus, Inc NYSE: MMS is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children's Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source